RareSight

RareSight is a healthtech start-up on a mission to radically shorten the diagnostic journey for people with rare diseases. Today, patients face an average diagnostic delay of 6-8 years. We believe that’s 6-8 years too long. Our AI-powered clinical decision support platform helps healthcare professionals detect rare conditions earlier by analyzing complex symptom patterns, integrating clinical data, and surfacing diagnostic suggestions grounded in the latest medical knowledge. We combine systems biology, machine learning, and clinician-friendly design to empower faster, more accurate diagnoses — and ultimately, better outcomes for patients. Currently in development, RareSight aims to launch in Switzerland by the end of Q3 2026.